🇺🇸 FDA
Patent

US 6387923

Imminoribitol PNP inhibitors, preparation thereof and use thereof

expired A61PA61P35/00

Quick answer

US patent 6387923 (Imminoribitol PNP inhibitors, preparation thereof and use thereof) held by BioCryst Pharmaceuticals, Inc. expires Mon May 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
BioCryst Pharmaceuticals, Inc.
Grant date
Tue May 14 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61P, A61P35/00